The move will see the Dutch company gain a stronger foothold within the food and nutrition sector across the British Isles, and will expand its capabilities across the specialised health, sports and animal nutrition sectors.
IMCD will now take ownership of 100% of Willows Ingredients’ shares. The Irish company predominantly operates within its own domestic markets as well as the UK.
Bringing a team of 26 employees into the IMCD fold, the company reported revenues of approximately £23 million in 2024.
Through this acquisition, IMCD will be hoping to expand its existing presence in “high-growth” food and nutrition segments, as well as broadening its portfolio and British and Irish market access by integrating Willows Ingredients’ supplier partnerships into its wider business.
“This acquisition represents an important step in developing our food & nutrition activities across the region,” commented Paul Hanbury, managing director of IMCD UK & Ireland.
"Willows Ingredients has built an impressive portfolio of nutrition ingredients, and the team brings long-standing trusted customer relationships and valuable expertise across Ireland and the UK. By combining their strengths with IMCD’s global reach and formulation capabilities, we can create even greater opportunities for our customers and principals.”
“We are proud of the strong customer relationships our team has built in the specialised nutrition space,“ added David Scrivens, managing director at Willows Ingredients.
“By joining IMCD, we gain access to a global platform that will enable us to support our partners even more effectively. We look forward to contributing our knowledge and working alongside our new colleagues to deliver enhanced solutions for the market.”
Although the deal has not yet been finalised and is subject to customary closing conditions, IMCD says that it expects the transaction to close in the first quarter of 2026.
Headquartered in Rotterdam, IMCD employs more than 5,200 people worldwide and operates in over 60 countries.
Traded on the Amsterdam-based Euronext stock exchange, IMCD reported revenues of £4.2 billion in 2025.
